Development and validation of novel optical methods for direct screening of taste receptor activation
直接筛选味觉受体激活的新型光学方法的开发和验证
基本信息
- 批准号:10593556
- 负责人:
- 金额:$ 24.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-12-01 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdrenergic ReceptorAgonistAmino AcidsArrestinsAspergillus flavusAspergillus fumigatusBacteriaBindingBinding ProteinsBiological AssayBiologyCalciumCalcium ChannelCalcium SignalingCellsClinicalComplex MixturesCouplesCultured CellsCyclic AMPDataDevelopmentEpithelial CellsEpitheliumExhibitsFamilyFluo 4FluorescenceFoodFutureG-Protein-Coupled ReceptorsGTP-Binding ProteinsGenetic TranscriptionGlutaminaseGlutamineHeterotrimeric GTP-Binding ProteinsHigh Pressure Liquid ChromatographyImmuneImmunologic ReceptorsInhalationInnate Immune ResponseLigandsMediatingMethicillinMethicillin ResistanceMethodsMolecularNatural ImmunityNutritional StudyOptical MethodsOpticsOrphanPathway interactionsPeptide HydrolasesPhospholipase CPhospholipases APhosphotransferasesPlant ExtractsPlayPotassium ChannelProtein IsoformsPseudomonas aeruginosaPublicationsPublishingQuinineReaderReceptor ActivationReportingResearchRoleSensorySignal PathwaySignal TransductionSignaling ProteinStaphylococcus aureusTaste BudsTaste PerceptionTestingTissuesTongueValidationVegetablesVisualizationWorkairway epitheliumarmcalcium indicatorclinically relevantexpression vectorfungushigh throughput screeningimprovedinsightinstrumentationnovelnutritionpathogenpathogenic bacteriapathogenic funguspreservationpreventrat Gnat3 proteinreceptorrespiratory smooth muscleresponsescreeningsweet receptorsweet taste perceptiontaste transductiontoolvoltage
项目摘要
PROJECT SUMMARY
Taste family 1 receptors (T1Rs, forming sweet and umami receptors) and taste family 2 receptors
(T2Rs, forming bitter receptors) are important G-protein couple receptors (GPCRs) expressed in taste buds of
the tongue. T1Rs and T2Rs also play important chemosensory roles in tissues all over the body, including the
airway epithelium and in immune cells. We and other have characterized T1Rs and T2Rs as novel players in
innate immunity. They detect bacterial metabolites to stimulate rapid innate immune responses.
While current screening methods have revealed a lot about specific agonists that activate specific T1Rs
and T2Rs, understanding T1R and T2R activation by complex mixtures (e.g., plant extracts or conditioned
media from bacteria) is currently very difficult. Existing screening methods are focused on calcium signaling as
a read-out. Many compounds activate calcium signals independently of taste receptors in cultured cells, and
the HEK293 cells commonly used express endogenous T2Rs. Calcium-focused screening methods have also
likely missed “biased agonists,” that is, agonists which do not activate T2R G protein signaling but activate
arrestin signaling. This has been reported for many GPCRs, but no one has yet screened for biased agonists
of taste receptors. This is a critical gap in the studies of T1R and T2R biology that will be addressed here.
To overcome limitations of calcium-based assays and reveal new insights into T2R-arrestin signaling,
we will adapt a fluorescence-based tripartite GFP-based assay (known as the TRIO assay) that directly
visualizes heterologously-expressed receptor activation through arrestin binding to the activated receptor. This
assay is much less limited by off-target effects of complex mixtures or single compounds compared with
current methods. It is also adaptable to high throughput plate-reader instrumentation. This assay is faster (1-2
hrs) than other GPCR assays which rely on transcription as a readout (12-24 hrs). We have utilized this assay
to study activation and inhibition of protease-activated and adrenergic receptors in prior studies. Preliminary
data suggest this assay works well with T2Rs. We hypothesize that T1R and T2R TRIO assays will reveal
novel ligand-T1R/T2R interactions and may be useful to de-orphanize the remaining orphan T2R isoforms.
In this proposal, Aim 1 will focus on validation of this optical assay using known bitter and sweet
compounds. Aim 2 will use this assay to screen taste receptors against common pathogenic bacteria and
fungi to characterize which receptors are activated by which pathogens. New clinically relevant data will be
revealed, and the expression constructs validated in this study will become useful tools for taste receptor
research. All expression vectors will be made widely available via Addgene after initial publication. This
research has important utility for both immune research as well as molecular sensory nutrition and taste
research.
项目概要
味觉家族 1 受体(T1R,形成甜味和鲜味受体)和味觉家族 2 受体
(T2R,形成苦味受体)是在味蕾中表达的重要 G 蛋白偶联受体 (GPCR)
T1R 和 T2R 在全身组织(包括舌头)中也发挥着重要的化学感应作用。
我们和其他人将 T1R 和 T2R 描述为新的参与者。
他们检测细菌代谢物以刺激快速的先天免疫反应。
虽然目前的筛选方法已经揭示了许多有关激活特定 T1R 的特定激动剂的信息
和 T2R,了解复杂混合物(例如植物提取物或条件化混合物)对 T1R 和 T2R 的激活
现有的筛选方法目前非常困难,主要集中在钙信号传导上。
许多化合物独立于培养细胞中的味觉受体激活钙信号,并且
常用的表达内源性 T2R 的 HEK293 细胞也有以钙为重点的筛选方法。
可能错过了“偏向激动剂”,即不激活 T2R G 蛋白信号传导但激活
许多 GPCR 都有这种情况的报道,但尚未有人筛选出有偏向的激动剂。
这是 T1R 和 T2R 生物学研究中的一个关键空白,本文将予以解决。
为了克服基于钙的检测的局限性并揭示对 T2R-arrestin 信号传导的新见解,
我们将采用基于荧光的三方 GFP 测定法(称为 TRIO 测定法),该测定法可直接
这通过视紫红质抑制蛋白与激活的受体结合来可视化异源表达的受体激活。
检测受到复杂混合物或单一比较化合物的脱靶效应的限制要小得多
它也适用于高通量酶标仪仪器,该测定速度更快 (1-2)。
小时)比其他依赖转录作为读数的 GPCR 测定(12-24 小时)我们使用了这种测定。
研究前期研究中蛋白酶激活受体和肾上腺素受体的激活和抑制。
数据表明该测定与 T2R 配合良好,我们希望 T1R 和 T2R TRIO 测定能够揭示这一点。
新的配体-T1R/T2R 相互作用,可能有助于去孤儿化剩余的孤儿 T2R 亚型。
在本提案中,目标 1 将重点关注使用已知的苦味和甜味来验证这种光学测定
目标 2 将使用该测定来筛选针对常见病原菌和化合物的味觉受体。
真菌来表征哪些受体被哪些病原体激活将是新的临床相关数据。
揭示了,本研究中验证的表达结构将成为味觉受体的有用工具
所有表达载体将在首次发表后通过 Addgene 广泛提供。
研究对于免疫研究以及分子感官营养和味觉具有重要用途
研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert J. Lee其他文献
Chapter 11 – Vision Corrections for the Older Adult
第 11 章 – 老年人视力矫正
- DOI:
- 发表时间:
2007 - 期刊:
- 影响因子:0
- 作者:
Robert J. Lee;R. Tahran - 通讯作者:
R. Tahran
Growth inhibition and chemosensitization of human carcinoma cells by human serum albumin-coated liposomal antisense oligodeoxyribonucleotide against bcl-2
人血清白蛋白包被的脂质体反义bcl-2寡脱氧核糖核苷酸对人癌细胞的生长抑制和化疗增敏作用
- DOI:
- 发表时间:
2012 - 期刊:
- 影响因子:6
- 作者:
Wanlop Weecharangsan;Robert J. Lee - 通讯作者:
Robert J. Lee
Frequency‐Force Behavior of in Situ Ventricular Myocardium in the Dog
狗原位心室心肌的频率-力行为
- DOI:
- 发表时间:
1971 - 期刊:
- 影响因子:0
- 作者:
F. Kavaler;R. Harris;Robert J. Lee;V. J. Fisher - 通讯作者:
V. J. Fisher
A transferrin receptor-targeted liposomal formulation for docetaxel.
一种针对转铁蛋白受体的多西紫杉醇脂质体制剂。
- DOI:
- 发表时间:
2010 - 期刊:
- 影响因子:0
- 作者:
G. Zhai;Jun Wu;Bo Yu;Chenyu Guo;Xingguo Yang;Robert J. Lee - 通讯作者:
Robert J. Lee
Robert J. Lee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert J. Lee', 18)}}的其他基金
Bitter and sweet taste receptor physiology in airway ciliated cells
气道纤毛细胞中的苦味和甜味受体生理学
- 批准号:
10440041 - 财政年份:2021
- 资助金额:
$ 24.38万 - 项目类别:
Bitter and sweet taste receptor physiology in airway ciliated cells
气道纤毛细胞中的苦味和甜味受体生理学
- 批准号:
10355475 - 财政年份:2018
- 资助金额:
$ 24.38万 - 项目类别:
Bitter and sweet taste receptor physiology in airway ciliated cells
气道纤毛细胞中的苦味和甜味受体生理学
- 批准号:
10573731 - 财政年份:2018
- 资助金额:
$ 24.38万 - 项目类别:
Bitter and sweet taste receptor physiology in airway ciliated cells
气道纤毛细胞中的苦味和甜味受体生理学
- 批准号:
9521663 - 财政年份:2018
- 资助金额:
$ 24.38万 - 项目类别:
Sweet receptor (T1R2/3) signaling in the upper airway and regulation of immunity
上呼吸道中的甜味受体 (T1R2/3) 信号转导和免疫调节
- 批准号:
8958191 - 财政年份:2015
- 资助金额:
$ 24.38万 - 项目类别:
Sweet receptor (T1R2/3) signaling in the upper airway and regulation of immunity
上呼吸道中的甜味受体 (T1R2/3) 信号转导和免疫调节
- 批准号:
9284440 - 财政年份:2015
- 资助金额:
$ 24.38万 - 项目类别:
相似国自然基金
内皮β3肾上腺素能受体调控线粒体功能参与血管衰老的作用研究
- 批准号:82370408
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
肾上腺素能受体激动剂引起睑板腺功能障碍发病的机制研究
- 批准号:82371024
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
α1-和β3-肾上腺素能受体的荧光探针可视化研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
β2肾上腺素能受体调控皮肤角化细胞活化在慢性重叠型疼痛状态中的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
苯乙酰谷氨酰胺通过beta-2肾上腺素能受体调节小胶质细胞活化参与糖尿病视网膜病变炎症的机制研究
- 批准号:82171071
- 批准年份:2021
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 24.38万 - 项目类别:
Structural basis for regulation of beta2 adrenergic receptor signaling by the dynamic post-translational modification S-palmitoylation
动态翻译后修饰S-棕榈酰化调节β2肾上腺素受体信号传导的结构基础
- 批准号:
10603466 - 财政年份:2023
- 资助金额:
$ 24.38万 - 项目类别:
The role of the endothelial NPYR1-TRPC3-ET1 signaling axis in neurovascular coupling dysfunction
内皮NPYR1-TRPC3-ET1信号轴在神经血管耦合功能障碍中的作用
- 批准号:
10667097 - 财政年份:2023
- 资助金额:
$ 24.38万 - 项目类别:
An Enzyme-Based Antidote for Acute Nicotine Toxicity
一种基于酶的急性尼古丁中毒解毒剂
- 批准号:
10790758 - 财政年份:2023
- 资助金额:
$ 24.38万 - 项目类别:
Mechanisms of L-type Calcium Channel Regulation in Heart Health and Disease
L 型钙通道在心脏健康和疾病中的调节机制
- 批准号:
10734121 - 财政年份:2023
- 资助金额:
$ 24.38万 - 项目类别: